Rothberg J - Search Results

1

Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.

Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Dhingra K, et al. Among authors: rothberg j. Leukemia. 1991 Mar;5(3):191-5. Leukemia. 1991. PMID: 2013978

2

A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.

Talpaz M, Kurzrock R, Kantarjian H, Rothberg J, Saks S, Evans L, Gutterman JU. Talpaz M, et al. Among authors: rothberg j. Cancer. 1991 Nov 15;68(10):2125-30. doi: 10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q. Cancer. 1991. PMID: 1913450 Clinical Trial.

3

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Kurzrock R, et al. Among authors: rothberg j. Cancer Res. 1993 May 1;53(9):2118-22. Cancer Res. 1993. PMID: 8481913

4

A phase-I clinical study of low-dose oral interferon-alpha.

Dhingra K, Duvic M, Hymes S, McLaughlin P, Rothberg J, Gutterman JU. Dhingra K, et al. Among authors: rothberg j. J Immunother Emphasis Tumor Immunol. 1993 Jul;14(1):51-5. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8399070 Clinical Trial.

5

A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinum.

Dhingra K, Talpaz M, Dhingra HM, Ajani JA, Rothberg JM, Gutterman JU. Dhingra K, et al. Among authors: rothberg jm. Invest New Drugs. 1991 Feb;9(1):37-9. doi: 10.1007/BF00194542. Invest New Drugs. 1991. PMID: 1851142 Clinical Trial.

6

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.

Lee KH, Talpaz M, Rothberg JM, Murray JL, Papadopoulos N, Plager C, Benjamin R, Levitt D, Gutterman J. Lee KH, et al. Among authors: rothberg jm. J Clin Oncol. 1989 Nov;7(11):1726-32. doi: 10.1200/JCO.1989.7.11.1726. J Clin Oncol. 1989. PMID: 2809685

7

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma.

Eton O, Talpaz M, Lee KH, Rothberg JM, Brell JM, Benjamin RS. Eton O, et al. Among authors: rothberg jm. Cancer. 1996 Mar 1;77(5):893-9. Cancer. 1996. PMID: 8608480 Clinical Trial.

8

LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.

Beeharry N, Landrette S, Gayle S, Hernandez M, Grotzke JE, Young PR, Beckett P, Zhang X, Carter BZ, Andreeff M, Halene S, Xu T, Rothberg J, Lichenstein H. Beeharry N, et al. Among authors: rothberg j. Blood Adv. 2019 Nov 26;3(22):3661-3673. doi: 10.1182/bloodadvances.2019001068. Blood Adv. 2019. PMID: 31751472 Free PMC article.

9

Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.

Gayle S, Landrette S, Beeharry N, Conrad C, Hernandez M, Beckett P, Ferguson SM, Mandelkern T, Zheng M, Xu T, Rothberg J, Lichenstein H. Gayle S, et al. Among authors: rothberg j. Blood. 2017 Mar 30;129(13):1768-1778. doi: 10.1182/blood-2016-09-736892. Epub 2017 Jan 19. Blood. 2017. PMID: 28104689 Free PMC article.

10

B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition.

Gayle S, Landrette S, Beeharry N, Conrad C, Hernandez M, Beckett P, Ferguson SM, Xu T, Rothberg J, Lichenstein H. Gayle S, et al. Among authors: rothberg j. Autophagy. 2017 Jun 3;13(6):1082-1083. doi: 10.1080/15548627.2017.1304871. Epub 2017 Mar 28. Autophagy. 2017. PMID: 28350209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters